Death by heartbreak doesn't just happen in stories. In real life, severe stress can cause the sometimes-fatal takotsubo syndrome.
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) released topline results from its Phase 2 FIGHT DMD trial. The study evaluated ...
Cumberland Pharmaceuticals’ Duchenne muscular dystrophy (DMD) drug has improved the amount of blood pumped by the heart, ...
Obesity significantly impacts cardiovascular health, increasing risks such as left ventricular hypertrophy, atherosclerosis, ...
There is an unmet need for therapies targeting Duchenne muscular dystrophy (DMD)–related heart disease, and phase 2 results ...
The new ACC and AHA criteria for cardiac devices emphasize more risk stratification, reflecting advances in the field in ...
Duchenne muscular dystrophy (DMD) treatment ifetroban led to improvements in measures of heart function in a Phase 2 clinical ...
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company with development efforts focused on new products for rare diseases, today announced positive top-line results from ...
Berlin: Bayer has announced the submission of a marketing authorization application to the European Medicines Agency (EMA), ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback